©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7190-7206
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7190
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7190
Table 3 Site of inflammation on abdominal computed tomography in the programmed cell death-1/programmed death-ligand 1 and cytotoxic T-lymphocyte antigen 4 groups
| Site of inflammation | PD-1/PD-L1, n = 23 | CTLA-4, n = 8 |
| Jejunum, n (%) | 1 (4.3) | 2 (25.0) |
| Ileum, n (%) | 2 (8.7) | 2 (25.0) |
| Cecum, n (%) | 2 (8.7) | 2 (25.0) |
| Ascending colon, n (%) | 3 (13.0) | 4 (50.0) |
| Transverse colon, n (%) | 3 (13.0) | 3 (37.5) |
| Descending colon, n (%) | 6 (26.1) | 3 (37.5) |
| Sigmoid colon, n (%) | 7 (30.4) | 2 (25.0) |
| Rectum, n (%) | 8 (34.8) | 2 (25.0) |
| No findings, n (%) | 9 (39.1) | 2 (25.0) |
- Citation: Yamada K, Sawada T, Nakamura M, Yamamura T, Maeda K, Ishikawa E, Iida T, Mizutani Y, Kakushima N, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Furune S, Hase T, Yokota K, Maeda O, Hashimoto N, Akiyama M, Ando Y, Fujishiro M. Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival. World J Gastroenterol 2021; 27(41): 7190-7206
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7190.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7190